Amplyx Pharmaceuticals' Series B - II Round

Amplyx Pharmaceuticals raised a round of funding on February 09, 2016. Investors include 3x5 Special Opportunity Partners.

Amplyx Pharmaceuticals is a pre-clinical stage small molecule drug development company with a portfolio of internally discovered candidates with improved the therapeutic properties. Amplyx's platform …

Articles about Amplyx Pharmaceuticals' Series B - II Round: